Viewing Study NCT06530706



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06530706
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-29

Brief Title: Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate whether esketamine can relieve anxiety in patients undergoing abdominal tumor surgery
Detailed Description: Hamilton anxiety Scale was used to screen patients with anxiety Only patients with score 8 were enrolled These patients were randomly assigned to the experimental group and control group

All patients enrolled were evaluated with Hamilton anxiety Scale PHQ-8 scale QoR-15 Scale and Athens Insomnia Scale After induction sevoflurane and remifentanil were used to maintain anesthesia The experimental group had esketamine while the control group had normal saline Athens Insomnia Scale was used to assess the sleep status 1 2 3 days after surgery and 1 month after surgery Hamilton anxiety Scale was used to evaluate the anxiety state of the patients 3 days after surgery and 1 month after surgery PHQ-8 scale QoR-15 Scale were collected 3 days after surgery and 1 month after surgery

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None